Labiotech.eu

News and Trends 19 Aug 2015

Sobi gets a long-lasting grip on a rare type of Hemophilia

In the 19th century, Queen Victoria passed the Hemophilia B to diverse royal houses of Europe. Today, its characteristic heavy bleedings can be treated quite well, as Swedish Orphan Biovitrum (Sobi) and its partner Biogen showed in the results of an ongoing long-term study. Sobi was formed in 2001 through a fusion of several units […]

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Paris is Europe’s biggest Biocluster, but nobody knows it …

Paris is well-known for being the most beautiful city in the world. But did you also know that it concentrates most of the French Biotech industry and is Europe’s biggest biocluster? If not, why didn’t you know? The Eiffel Tower, the Louvre, Notre Dame and so many other monuments makes Paris outstanding and unique. But Paris […]

August 19, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 19 Aug 2015

Top 5 Biotech Books to Enjoy your Summer on the Beach

Summer is a great time to read books and get inspired for the year to come. Here’s a Top 5 list of my recommendations to read before summer ends. 1. Genentech: The Beginnings of Biotech Genentech is considered the founder of the Biotech industry in the late 80s. It started from breakthrough science, crazy scientists and very risk-taking […]

August 19, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

New mAb-treatment Improves the Life of European Children with Neuroblastoma

The European Commission granted marketing authorisation for United Therapeutics‘ Unituxin for the treatment of neuroblastoma in patients aged 12 months to 17 years. In Europe, approximately 1500 patients are diagnosed with neuroblastoma, the most common cancer in children. Some patients – the low-risk and intermediate risk group – are favored by an excellent prognosis with cure rates […]

August 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

Not only Genes matter, Cellular Origin determines the Cancer Type

Cancer occurs in uncountable forms, and we are far away from understanding all the mechanisms that lead to its variety. For example, did you know that not only the mutated gene is responsible for the emerging of a certain type of cancer but also its cellular origin? That’s what researcher from Belgium and Australia just […]

August 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 18 Aug 2015

Fresh money for Kuros to Speed up Bone repair

Kuros Biosurgery raised CHF15 million (€13.8M) to bring its late stage bone-repairing agents to the market. A second financing round is already planned for later this year. Bones can suffer a lot during surgeries, sports or severe accidents. To accelerate its healing, Swiss Kuros has established a late stage pipeline of bone-repairing agents. The company was […]

August 18, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 17 Aug 2015

Pfizer uses HiFiBiO’s brand-new technology to discover unique antibodies

French biotech startup HiFiBiO announced today it has achieved a milestone in its research collaboration with American giant Pfizer to develop new antibody therapeutics. The new milestone is triggering an undisclosed payment to HiFiBiO. The focus of the collaboration, originally signed in 2014, is the development and validation of HiFiBiO’s proprietary, high throughput antibody discovery platform […]

August 17, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 17 Aug 2015

Genmab’s Bispecific Antibodies Catch Another Big Fish

Genmab, the Danish company developing the DuoBody technology platform to create and develop bispecific antibody candidates, just signed another licensing agreement with a Big Pharma company. This time, Novo Nordisk has been caught in a potential $502 million (€453m) deal. The DuoBody technology involves three basic steps to generate stable bispecific human IgG1 antibodies. In the first step, […]

August 17, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 17 Aug 2015

What if the Best Coffee could be obtained thanks to Biotechnologies?

French bioengineers Camille Delebecque and Sophie Deterre founded the food Start-up Afineur in New York to revolutionize coffee. You may have heard of the Kopi Luwak or Civet Coffee from Indonesia. If not, it’s a very special coffee and one of the most expensive with prices reaching €550/kg. The raw coffee beans are eaten by Asian Palm […]

August 17, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 16 Aug 2015

What happened this week? Woodford spent €800m, CRISPR discoverer moves to Berlin, the first Bacteria-made ink…

Encouraging facts for the European Biotech ecosystem this week! Neil Woodford’s mega Biotech fund is gathering new money to pour over the European companies. Definitely good news for the financing of companies in Europe, which still lags behind the US. Another interesting fact is that one of the co-discoverer of CRISPRs, the biggest discovery of the century, […]

August 16, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 15 Aug 2015

The Sky is the Limit: Novo Nordisk continues to rise

The world’s leading insulin supplier, Novo Nordisk, turns in a superb performance in the first six months of 2015. Sales revenues increased, two IIIa trials were successfully completed and two new treatments are now available on the huge diabetes market of the US. We visited Denmark for our last Labiotech tour. We knew Novo was […]

August 15, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 14 Aug 2015

Milestone in Stem Cell Research: European Researchers grow Millimeter-Long Muscle Fibers!

Stem cell research grows and grows in Europe! For the first time ever, researchers succeded to effectively grow a large number of muscle cells derived from pluripotent stem cells! Researchers from six European countries are participating in the PluriMes project to give a cutting edge to the European stem cell research. Launched in February 2014, […]

August 14, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Sobi gets a long-lasting grip on a rare type of Hemophilia

Paris is Europe’s biggest Biocluster, but nobody knows it …

Top 5 Biotech Books to Enjoy your Summer on the Beach

New mAb-treatment Improves the Life of European Children with Neuroblastoma

Not only Genes matter, Cellular Origin determines the Cancer Type

Fresh money for Kuros to Speed up Bone repair

Pfizer uses HiFiBiO’s brand-new technology to discover unique antibodies

Genmab’s Bispecific Antibodies Catch Another Big Fish

What if the Best Coffee could be obtained thanks to Biotechnologies?

What happened this week? Woodford spent €800m, CRISPR discoverer moves to Berlin, the first Bacteria-made ink…

The Sky is the Limit: Novo Nordisk continues to rise

Milestone in Stem Cell Research: European Researchers grow Millimeter-Long Muscle Fibers!

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!